ULURU Inc. (OTCMKTS:ULUR) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersItem 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Engagement of Chief Financial Officer. On December 4, 2018 (the “Effective Date”), ULURU Inc. (the “Company”) entered into a Financial Services Consulting Agreement (the “Consulting Agreement”) with Ram Associates LLC (the “Consultant”) to which Consultant will be providing accounting services similar to those that would be provided by a controller and a chief financial officer. to the Agreement, beginning on the Effective Date, Consultant will provide accounting support and other controller services for the Company. Beginning on January 1, 2018, P.K. Ramachandran, a representative of Consultant, will act as Chief Financial Officer of the Company. In exchange for its services, the Company will pay Consultant $5,833.33 per month beginning December 1, 2018.
Mr. Ramachandran, age 65, is a certified public accountant and has over 40 years of experience both in corporate and public accounting. Currently, Mr. Ramachandran is the Managing Partner of Ram Associates and Co. LLC, an accounting consulting firm, which he founded in 1984. Since starting Ram Associates, Mr. Ramachandran has acquired valuable experience with several successful start-up businesses spread over various industry sectors and dealing with the external financial community. Mr. Ramachandran is a member of the American Society and the New Jersey Society of Certified Public Accountants and is a graduate of the Calcutta University, India.
Termination of Chief Financial Officer. On December 3, 2018, the Company notified Terrance K. Wallberg, the Vice President, Secretary, Treasurer, and Chief Financial Officer of the Company, of its decision to terminate his services as Vice President, Secretary, Treasurer, and Chief Financial Officer effective on a date to be determined during December 2018. As of the date of this filing, the Company has not entered into a separation agreement with Mr. Wallberg with respect to his separation. Absent any separation agreement, in connection with his separation, Mr. Wallberg will be entitled to a payment of all accrued but unpaid compensation through the date of termination.
ULURU Inc. ExhibitEX-10.1 2 ex_10-1.htm FINANCIAL SERVICES CONSULTING AGREEMENT WITH RAM ASSOCIATES LLC ULURU Inc. FINANCIAL SERVICES CONSULTING AGREEMENT (Ram Associates LLC) This Consulting Agreement is entered into as of December 4,…To view the full exhibit click here
About ULURU Inc. (OTCMKTS:ULUR)
ULURU Inc. is a specialty pharmaceutical company focused on developing and commercializing a range of wound care and muco-adhesive film products based on its Nanoflex and OraDisc technologies for patients, healthcare professionals and healthcare payers. The Company operates through the research, development and commercialization of pharmaceutical products segment. Utilizing its technologies, three of its products have been approved for marketing in various global markets. Altrazeal Transforming Powder Dressing is based on its Nanoflex technology, which changes the way healthcare providers approach their treatment of wounds. The product is indicated for both exuding acute wounds, such as donor sites, non-healing surgical wounds, and trauma and for chronic wounds, such as venous leg ulcers, diabetic foot ulcers and pressure ulcers. Aphthasol is a drug approved for the treatment of canker sores. OraDisc is developed as an improved drug delivery system for the treatment of canker sores.